  | Bontems, S., BOREUX, R., CAPRARO, V., Huynen, P., DESCY, J., Melin, P., Hayette, M.-P., & MEEX, C. (2019). Evaluation of the Abbott RealTime quantitative CMV and EBV assays using the maxCycle protocol in a laboratory automation context. Journal of Virological Methods, 270, 137-145. doi:10.1016/j.jviromet.2019.05.007  Peer Reviewed verified by ORBi |
 | BONTEMS, S., BOREUX, R., CAPRARO, V., HUYNEN, P., DESCY, J., MELIN, P., HAYETTE, M.-P., & MEEX, C. (April 2017). Evaluation of the Abbott RealTime CMV and EBV assays on the m2000 (Abbott) platform [Poster presentation]. ECCMID, Vienne, Austria. |
 | BOEMER, F., Fasquelle, C., D'OTREPPE DE BOUVETTE, S., JOSSE, C., DIDEBERG, V., SEGERS, K., GUISSARD, V., CAPRARO, V., Debray, F.-G., & Bours, V. (2017). A next-generation newborn screening pilot study: NGS on dried blood spots detects causal mutations in patients with inherited metabolic diseases. Scientific Reports, 7 (1), 17641. doi:10.1038/s41598-017-18038-x Peer Reviewed verified by ORBi |
  | Karam, M., Thenoz, M., CAPRARO, V., Robin, J.-P., Pinatel, C., Lancon, A., Galia, P., Sibon, D., Thomas, X., Ducastelle-Lepretre, S., Nicolini, F., El-Hamri, M., Chelghoun, Y., Wattel, E., & Mortreux, F. (2014). Chromatin redistribution of the DEK oncoprotein represses hTERT transcription in leukemias. Neoplasia, 16 (1), 21-30. doi:10.1593/neo.131658 Peer Reviewed verified by ORBi |
 | KROONEN, J.* , Artesi, M.* , CAPRARO, V., Nguyen-Khac, M.-T., Willems, M., Chakravarti, A., Bours, V., & Robe, P. (2012). Casein kinase 2 inhibition modulates the DNA damage response but fails to radiosensitize malignant glioma cells. International Journal of Oncology, 41 (2), 776-82. doi:10.3892/ijo.2012.1489 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Zane, L., Sibon, D., CAPRARO, V., Galia, P., Karam, M., Delfau-Larue, M.-H., Gilson, E., Gessain, A., Gout, O., Hermine, O., Mortreux, F., & Wattel, E. (2012). HTLV-1 positive and negative T cells cloned from infected individuals display telomerase and telomere genes deregulation that predominate in activated but untransformed CD4+ T cells. International Journal of Cancer, 131 (4), 821-33. doi:10.1002/ijc.26270 Peer Reviewed verified by ORBi |
 | Kroonen, J., Nassen, J., Boulanger, Y.-G., Provenzano, F., Capraro, V., Bours, V., Martin, D., Deprez, M., Robe, P., & Rogister, B. (2011). Human glioblastoma-initiating cells invade specifically the subventricular zones and olfactory bulbs of mice after striatal injection. International Journal of Cancer, 129 (3), 574-585. doi:10.1002/ijc.25709 Peer Reviewed verified by ORBi |
 | CAPRARO, V., Zane, L., Poncet, D., Perol, D., Galia, P., Preudhomme, C., Bonnefoy-Berard, N., Gilson, E., Thomas, X., El-Hamri, M., Chelghoun, Y., Michallet, M., Wattel, E., Mortreux, F., & Sibon, D. (2011). Telomere deregulations possess cytogenetic, phenotype, and prognostic specificities in acute leukemias. Experimental Hematology, 39 (2), 195-202.e2. doi:10.1016/j.exphem.2010.10.008 Peer reviewed |